Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies

Clinical Neuropathology

Volumn 21, Issue 6, 2002, Pages 252-257

  Torp, Sverre H ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Brain tumors; Gliomas; MIB1; Proliferation; Survival

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NORMAL VALUE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIBODIES; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ASTROCYTOMA; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0036855323     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bouvier-Labit C, Chinot O, Ochi C, Gambarelli D, Dufourt H, Figarella-Branger D 1998 Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol Appl Neurobiol 24: 381-388
2. Cunningham JM, Kimmel DW, Scheithauer BW, O'Fallon JR, Novotny PJ, Jenkins RB 1997 Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value. J Neurosurg 86: 121-130
3. Di X, Nishizaki T, Harada K, Kajiwara K, Nakayama H, Ito H 1997 Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1. J Exp Clin Cancer Res 16: 389-394
4. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO 1995 Prognostic indicators in a range of astrocytic tumors: An immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry 59: 413-419
5. Eneström S, Vavruch L, Frånlund B, Nordenskjöld B 1998 Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas. Neurochirurgie 44: 25-30
6. Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ, Forsyth PA, Hayostek CJ 1999 Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol 58: 46-53
7. Hilton DA, Love S, Barber R, Ellison D, Sandeman DR 1998 Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurgery 42: 724-729
8. Hsu DW, Louis DN, Efird JT, Hedley-Whylef ET 1997 Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol 56: 857-865
9. Kiss R, Dewitte O, Decaestecker C, Camby I, Gordower L, Delbecque K, Pasteels J-L, Brotchi J, Salmon I 1997 The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol 107: 321-331
10. Kleihues P, Cavenee WK 2000 World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System. IARC Press, Lyon
11. Kleihues P, Davis RL, Ohgaki H, Burger PC, Westphal MM, Cavenee WK 2000 Diffuse astrocytoma. In: Kleihues P. Cavenee WK (eds) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System. IARC Press, Lyon, pp 22-26
12. Litofsky NS, Mix T-CH, Baker SP, Recht LD, Smith TW 1998 Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: No prognostic significance. Surg Neurol 50: 579-585
13. McKeever PE, Strawderman MS, Yamini B, Mikhail AA. Blaivas M 1998 MIB-1 proliferation index predicts survival among patients with grade II astrocytoma. J Neuropathol Exp Neurol 10: 931-936
14. Montine TJ, Vandersteenhoven JJ, Aguzzi A, Boyko OB, Dodge RK, Kerns B-J, Burger PC 1994 Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 34: 674-679
15. Sallinen PK, Haapasalo HK. Visakorpi T, Helén PT. Rantala IS, Isola JJ, Helin HJ 1994 Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffinembedded samples. J Pathol 174: 275-282
16. Sallinen PK, Sallinen S-L, Helén PT, Rantala IS, Rautiainen E, Helin HJ, Kalimo H, Haapasalo HK 2000 Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumors in the context of the WHO 1979 and WHO 1993 grading schemes. Neuropathol Appl Neurobiol 26: 319-331
17. Schiffer D, Cavalla P, Chiò A, Richiardi P, Giordana MT 1997 Proliferative activity and prognosis of low-grade astrocytomas. J Neuro-Oncol 34: 31-35
18. Tihan T, Davis R, Elowitz E, DiCostanzo D, Moll U 2000 Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas. Arch Pathol Lab Med 124: 108-113
19. Torp SH, Johannesen E, Lindboe CF 1995 Comparison of different Ki67 antibodies in human glioblastomas. J Clin Pathol Mol Pathol 48: M191-193
20. Torp SH 1997 Proliferative activity in human glioblastomas: Evaluation of different Ki67 equivalent antibodies. Mol Pathol 50: 198-200
21. Torp SH, Granli US 2001 Proliferative activity in human glioblastomas assessed by various techniques. APMIS 109: 865-869
22. Torp SH, Lindboe CF, Granli US, Moen TM, Nordtømme T 2001 Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas. Clin Neuropathol 20: 190-195
23. Torp SH, Alsaker M 2002 Ki-67 immunoreactivity, basic fibroblast growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-67 antibodies. Pathol Res Pract 198: 261-265
24. Wakimoto H, Aoyagi M, Nakayama T, Nagashima G, Yamamoto S, Tamaki M, Hirakawa K 1996 Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77: 373-380